InvestorsHub Logo
Followers 126
Posts 15365
Boards Moderated 2
Alias Born 06/29/2006

Re: GVX808 post# 16520

Friday, 04/28/2023 7:53:37 PM

Friday, April 28, 2023 7:53:37 PM

Post# of 16698
After a couple Reverse’s which works out to 1 share from 200 then Forward 4 from 1

So real claim is 1 share from 50

Rights were right to give to holders of shares for .18 $AGNPF or .25 $AGN

I hope it shows 9.6 bought the Right for .18 $AGNPF or .25 $AGN

$2.5M CAD for the Company for $Cash on hand to pay Expenses

Plus those Buying $2.5M @ .18 $AGNPF or .25 $AGN are the shareholders already so the bottom is in

JMO — Expect it to look as a fall but it will be a fake and any wanting to Jump will be bought, has to be better than .18 $AGNPF or .25 $AGN for $2.5M CAD investment — No need to run it up if they can get Shareholders to Jump on keeping it low and Jumpers jump

Another Opinion — News will come but probably guided to sell the $10M USD Nasdaq shares of Algernon NeuroScience Announces U.S. SEC Qualification of Regulation A+ Tier II Offering to Raise up to USD $10M

Under the Reg A+, AGN Neuro will be offering up to 37.5% of its common shares, with majority ownership residing with AGN Pharma.

Meaning if all the Rights get bought

19.3M Outstanding worth $20M USD

$1.03 $AGNPF

Remember the 1 from 50 Splits ?

Gain of .02 $AGNPF if & only if they sell 37.5% $10M Nasdaq Buyers and leave 62.5% for holders in $AGNPF & $AGN

Time for Shareholders to be rewarded some gain somewhere

Yeah I believe News will be quite to get Jumpers to jump and then when their ready for the $10M Nasdaq Investment — News will hit just before Buyers can Buy

JMO